Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 |
|---|---|---|---|
| Revenue | 3.72bn | 3.12bn | 2.39bn |
| Cost of revenue | 238m | 143m | 33m |
| Research and development | 1.61bn | 1.41bn | 1.11bn |
| Selling, general and administrative | 626m | 549m | 478m |
| Operating income | 1.07bn | 972m | 772m |
| Pre-tax income | 1.20bn | 1.33bn | 817m |
| Income tax | 241m | 193m | 186m |
| Net income | 963m | 1.13bn | 4.35bn |
| Earnings per share | 15.50 | 17.66 | 9.67 |
| Earnings per share, diluted | 15.37 | 121.36 | 66.02 |
| Metric | Aug 18, 2026 | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|---|
| Cash and equivalents | — | 1.72bn | 1.38bn | 2.20bn | 1.42bn |
| Receivables | — | 1.11bn | 923m | 733m | — |
| Inventory | — | 18m | 9m | 8m | — |
| Current assets | — | 2.89bn | 3.90bn | 4.91bn | — |
| Property, plant and equipment | — | 153m | 137m | 142m | — |
| Goodwill | — | 355m | 355m | 0 | — |
| Total assets | — | 12.87bn | 45.81bn | 35.29bn | — |
| Current liabilities | — | 1.43bn | 744m | 368m | — |
| Short-term debt | — | 273m | 0 | 0 | — |
| Long-term debt | — | 5.00bn | 0 | 0 | — |
| Total liabilities | — | 7.03bn | 9.11bn | 545m | — |
| Equity | — | 5.85bn | 36.70bn | 31.61bn | 3.92bn |
| Metric | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 |
|---|---|---|---|
| Operating cash flow | 1.19bn | 1.13bn | 1.07bn |
| Share-based compensation | 128m | 105m | 85m |
| Capital expenditure | 37m | 27m | 53m |
| Investing cash flow | −5.64bn | −9.91bn | −185m |
| Financing cash flow | 4.79bn | −3.92bn | −606m |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)